CAM Type: biologically based
Common Names: 5-HTP
Introduction to 5-HTP:
5-Hydroxytryptophan is a precursor to the neurotransmitter
serotonin and an intermediate in tryptophan metabolism. It is marketed in
the US and other countries as a dietary supplement for use as an appetite suppressant,
antidepressant and a sleep aid.
5-HTP has been shown useful in some conditions characterized, in part, by
serotonin deficits, especially depression. It has also been shown to be useful
in some people with insomnia, obesity, chronic tension headache and fibromyalgia.
Intestinal absorption of 5-HTP does not require a transport molecule, and
is not affected by the presence of other amino acids; therefore it can be taken
with food without reducing its effectiveness. Unlike L-tryptophan, 5-HTP cannot
be shunted into niacin or protein production.
CAM therapy practitioners often recommend 5-HTP instead of standard SSRIs
or MAOIs, as 5-HTP is believed to accomplish the same goal without resorting
to disturbing the brain’s natural metabolic procedures, as many drugs
do.
Preparation Methods:
5-HTP is found in infinitesimal amounts in numerous
foods like turkey and dairy products, and is often sold as an over-the-counter
(OTC) supplement. In this case it is usually derived from the seeds of the
Griffonia simplicifolia plant. Production of 5-HTP soared when L-tryptophan,
a similar serotonin-altering supplement, was banned in the United States
after a tainted batch caused severe adverse effects in users.
Pharmacology:
5-HTP’s psychoactive action is believed to derive from its effect on
serotonin synthesis. It is believed that an artificially high level of 5-HTP
causes the brain’s serotonin-producing neurons to increase production.
Increased serotonin production leads to increased release.
Some clinicians suggest that 5-HTP be administered with a peripheral decarboxylase
inhibitor (such as carbidopa) to prevent elevated serotonin levels in the bloodstream
(and the subsequent side effects).
Mechanisms of Action:
The mechanism of the possible antidepressant effects of 5-HTP is accounted
for by its conversion to the neurotransmitter serotonin which plays a key role
in the affective state. Antidepressants may work by either binding to one or
more of the 5-HT receptors or by inhibiting serotonin reuptake. Some evidence
suggests that 5-HTP has some analgesic activity with fibromyalgia, and in one
study, it was found to have some benefits in those with chronic tension headache.
This may be accounted for, in part, by its conversion to serotonin.
CLICK FOR RELATED CONTENT |
|
Safety, Side Effects and Warnings:
5-HTP should not be used by those hypersensitive to any component of a 5-HTP-containing
product. It is also contraindicated in people with carcinoid tumors, and during
or within 2 weeks after discontinuation of an MAOI.
Large doses of 5-HTP can trigger excess of serotonin formation in tissues
other than the target organ and cause significant adverse effects. It should
not be used concurrently with any antidepressant, including SSRIS, tricyclics,
or MAOIs. Concurrent 5-HTP use with an antidepressant may increase the risk
of adverse reactions. 5-HTP should not be used by those with ischemic heart
disease, coronary artery spasm, uncontrolled hypertension and any other significant
cardiovascular disease.
Some people taking 5-HTP have reported experiencing eosinophilia and eosinophilia-myalgia
syndrome (EMS). EMS is similar to that caused by L-tryptophan and was linked
to contaminants in 5-HTP’s preparation, rather than 5-HTP itself. Changing
the 5-HTP resolved the EMS in one group of patients. In some people taking
5-HTP in conjunction with carbidopa, a scleroderma-like skin condition has
been reported.
Other side effects reported include appetite loss, vomiting, difficulty breathing,
diarrhea, and nausea. Neurological side effects, including dilation of the
pupils, loss of muscle coordination, blurring of vision and abnormally sensitive
reflexes, have been reported in those taking large doses. Cardiac dysrhythmias
have also been reported by some.
Clinical Evidence:
Clinical References for 5-HTP
Author: Jase Donaldson